<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Harding Boone | Activity</title>
	<link>https://toxicdolls.com/members/llamaland42/activity/</link>
	<atom:link href="https://toxicdolls.com/members/llamaland42/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Harding Boone.</description>
	<lastBuildDate>Mon, 04 May 2026 08:35:57 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">51d8e4237e6de3bdae0edc7dc772fd04</guid>
				<title>Harding Boone posted an update: 77), and a similar degree of inflammation. Periapical lesions [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/7466/</link>
				<pubDate>Sun, 22 Jun 2025 10:45:41 +0000</pubDate>

									<content:encoded><![CDATA[<p>77), and a similar degree of inflammation. Periapical lesions (PALs) in all four molars were only identified in a small subset of Tx mice. CONCLUSIONS A novel mouse model, which combines AP and CVD, was created. This model allows investigation of the relationship between the two diseases, whilst avoiding other potential common confounders.&hellip;<span class="activity-read-more" id="activity-read-more-7466"><a href="https://toxicdolls.com/activity-2/p/7466/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3133c0e83d21369f4628ea3e1369968e</guid>
				<title>Harding Boone posted an update: OBJECTIVE We aimed to assess the efficacy and benefit-risk [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/5927/</link>
				<pubDate>Fri, 20 Jun 2025 21:32:58 +0000</pubDate>

									<content:encoded><![CDATA[<p>OBJECTIVE We aimed to assess the efficacy and benefit-risk profile of pregabalin (PGN) to reduce the clinical signs of central neuropathic pain (CNeP) as reflected by scratching episodes in dogs with symptomatic syringomyelia (SM). STUDY DESIGN Randomized, double-blind, placebo-controlled crossover study. ANIMALS A total of 12 client-owned&hellip;<span class="activity-read-more" id="activity-read-more-5927"><a href="https://toxicdolls.com/activity-2/p/5927/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7d56db27c519ea55f8f9b2d20989bedf</guid>
				<title>Harding Boone became a registered member</title>
				<link>https://toxicdolls.com/activity-2/p/5901/</link>
				<pubDate>Fri, 20 Jun 2025 21:00:49 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>